BCG Vaccine Industry Research Report 2024

BCG Vaccine Industry Research Report 2024


Summary

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

According to APO Research, the global BCG Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of BCG Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine.

The report will help the BCG Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The BCG Vaccine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
BCG Vaccine segment by Type

Immune BCG
Therapy BCG
BCG Vaccine segment by Application

Hospitals
Clinics
Others
BCG Vaccine Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of BCG Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of BCG Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global BCG Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global BCG Vaccine Sales (2019-2030)
2.2.3 Global BCG Vaccine Market Average Price (2019-2030)
2.3 BCG Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Immune BCG
2.3.3 Therapy BCG
2.4 BCG Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hospitals
2.4.3 Clinics
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global BCG Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global BCG Vaccine Sales (MT) of Manufacturers (2019-2024)
3.3 Global BCG Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global BCG Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global BCG Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of BCG Vaccine, Product Type & Application
3.8 Global Manufacturers of BCG Vaccine, Date of Enter into This Industry
3.9 Global BCG Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck BCG Vaccine Product Portfolio
4.1.5 Merck Recent Developments
4.2 Sanofi Pasteur
4.2.1 Sanofi Pasteur Company Information
4.2.2 Sanofi Pasteur Business Overview
4.2.3 Sanofi Pasteur BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
4.2.5 Sanofi Pasteur Recent Developments
4.3 Japan BCG Lab
4.3.1 Japan BCG Lab Company Information
4.3.2 Japan BCG Lab Business Overview
4.3.3 Japan BCG Lab BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
4.3.5 Japan BCG Lab Recent Developments
4.4 China National Biotec
4.4.1 China National Biotec Company Information
4.4.2 China National Biotec Business Overview
4.4.3 China National Biotec BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 China National Biotec BCG Vaccine Product Portfolio
4.4.5 China National Biotec Recent Developments
4.5 Serum Institute of India
4.5.1 Serum Institute of India Company Information
4.5.2 Serum Institute of India Business Overview
4.5.3 Serum Institute of India BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Serum Institute of India BCG Vaccine Product Portfolio
4.5.5 Serum Institute of India Recent Developments
4.6 Intervax
4.6.1 Intervax Company Information
4.6.2 Intervax Business Overview
4.6.3 Intervax BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Intervax BCG Vaccine Product Portfolio
4.6.5 Intervax Recent Developments
4.7 GSBPL
4.7.1 GSBPL Company Information
4.7.2 GSBPL Business Overview
4.7.3 GSBPL BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 GSBPL BCG Vaccine Product Portfolio
4.7.5 GSBPL Recent Developments
5 Global BCG Vaccine Market Scenario by Region
5.1 Global BCG Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global BCG Vaccine Sales by Region: 2019-2030
5.2.1 Global BCG Vaccine Sales by Region: 2019-2024
5.2.2 Global BCG Vaccine Sales by Region: 2025-2030
5.3 Global BCG Vaccine Revenue by Region: 2019-2030
5.3.1 Global BCG Vaccine Revenue by Region: 2019-2024
5.3.2 Global BCG Vaccine Revenue by Region: 2025-2030
5.4 North America BCG Vaccine Market Facts & Figures by Country
5.4.1 North America BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America BCG Vaccine Sales by Country (2019-2030)
5.4.3 North America BCG Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe BCG Vaccine Market Facts & Figures by Country
5.5.1 Europe BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe BCG Vaccine Sales by Country (2019-2030)
5.5.3 Europe BCG Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific BCG Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific BCG Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific BCG Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America BCG Vaccine Market Facts & Figures by Country
5.7.1 Latin America BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America BCG Vaccine Sales by Country (2019-2030)
5.7.3 Latin America BCG Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa BCG Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa BCG Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa BCG Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global BCG Vaccine Sales by Type (2019-2030)
6.1.1 Global BCG Vaccine Sales by Type (2019-2030) & (MT)
6.1.2 Global BCG Vaccine Sales Market Share by Type (2019-2030)
6.2 Global BCG Vaccine Revenue by Type (2019-2030)
6.2.1 Global BCG Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global BCG Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global BCG Vaccine Price by Type (2019-2030)
7 Segment by Application
7.1 Global BCG Vaccine Sales by Application (2019-2030)
7.1.1 Global BCG Vaccine Sales by Application (2019-2030) & (MT)
7.1.2 Global BCG Vaccine Sales Market Share by Application (2019-2030)
7.2 Global BCG Vaccine Revenue by Application (2019-2030)
7.2.1 Global BCG Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global BCG Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global BCG Vaccine Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 BCG Vaccine Value Chain Analysis
8.1.1 BCG Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 BCG Vaccine Production Mode & Process
8.2 BCG Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 BCG Vaccine Distributors
8.2.3 BCG Vaccine Customers
9 Global BCG Vaccine Analyzing Market Dynamics
9.1 BCG Vaccine Industry Trends
9.2 BCG Vaccine Industry Drivers
9.3 BCG Vaccine Industry Opportunities and Challenges
9.4 BCG Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings